Zoetis Declares Fourth Quarter 2022 Dividend
October 13 2022 - 5:15PM
Business Wire
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a
dividend of $0.325 per share for the fourth quarter of 2022. The
dividend will be paid on Thursday, December 1, 2022, to all holders
of record of the Company’s common stock as of the close of business
on Tuesday, November 1, 2022.
About Zoetis
As the world’s leading animal health company, Zoetis is driven
by a singular purpose: to nurture our world and humankind by
advancing care for animals. After 70 years innovating ways to
predict, prevent, detect, and treat animal illness, Zoetis
continues to stand by those raising and caring for animals
worldwide -- from livestock farmers to veterinarians and pet
owners. The company’s leading portfolio and pipeline of medicines,
vaccines, diagnostics and technologies make a difference in over
100 countries. A Fortune 500 company, Zoetis generated revenue of
$7.8 billion in 2021 with approximately 12,100 employees. For more
information, visit www.zoetis.com.
DISCLOSURE NOTICES
Forward-Looking Statements: This
press release contains forward-looking statements, which reflect
the current views of Zoetis with respect to business plans or
prospects, future operating or financial performance, future use of
cash and dividend payments, and other future events. These
statements are not guarantees of future performance or actions.
Forward-looking statements are subject to risks and uncertainties.
If one or more of these risks or uncertainties materialize, or if
management's underlying assumptions prove to be incorrect, actual
results may differ materially from those contemplated by a
forward-looking statement. Forward-looking statements speak only as
of the date on which they are made. Zoetis expressly disclaims any
obligation to update or revise any forward-looking statement,
whether as a result of new information, future events or otherwise.
A further list and description of risks, uncertainties and other
matters can be found in our Annual Report on Form 10-K for the
fiscal year ended December 31, 2021, including in the sections
thereof captioned “Forward-Looking Statements and Factors That May
Affect Future Results” and “Item 1A. Risk Factors,” in our
Quarterly Reports on Form 10-Q and in our Current Reports on Form
8-K. Such risks and uncertainties may be amplified by the COVID-19
pandemic and its potential impact on the global economy and our
business. These filings and subsequent filings are available online
at www.sec.gov, www.zoetis.com, or on request from Zoetis.
ZTS-COR ZTS-IR ZTS-FIN
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221013005994/en/
Media: Bill Price 1-973-443-2742
(o) william.price@zoetis.com Kristen Seely 1-973-443-2777 (o)
kristen.seely@zoetis.com Investor:
Steve Frank 1-973-822-7141 (o) steve.frank@zoetis.com Nick
Soonthornchai 1-973-443-2792 (o) nick.soonthornchai@zoetis.com
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jul 2023 to Jul 2024